Synergistic anti-tumor effect of combined inhibition of EGFR and JAK/STAT3 pathways in human ovarian cancer.
about
A loop of cancer-stroma-cancer interaction promotes peritoneal metastasis of ovarian cancer via TNFα-TGFα-EGFRSingle agent BMS-911543 Jak2 inhibitor has distinct inhibitory effects on STAT5 signaling in genetically engineered mice with pancreatic cancerExtracellular PKM2 induces cancer proliferation by activating the EGFR signaling pathway.Direct Upregulation of STAT3 by MicroRNA-551b-3p Deregulates Growth and Metastasis of Ovarian Cancer.Novel multiple tyrosine kinase inhibitor ponatinib inhibits bFGF-activated signaling in neuroblastoma cells and suppresses neuroblastoma growth in vivo.Niclosamide inhibition of STAT3 synergizes with erlotinib in human colon cancer.Bazedoxifene as a Novel GP130 Inhibitor for Pancreatic Cancer Therapy.Naringenin inhibits proliferation, migration, and invasion as well as induces apoptosis of gastric cancer SGC7901 cell line by downregulation of AKT pathway.Therapeutic strategies of drug repositioning targeting autophagy to induce cancer cell death: from pathophysiology to treatment.Anticancer effect of cucurbitacin B on MKN-45 cells via inhibition of the JAK2/STAT3 signaling pathway.Knockdown of long non-coding RNA MALAT1 inhibits growth and motility of human hepatoma cells via modulation of miR-195.Overcoming resistance of targeted EGFR monotherapy by inhibition of STAT3 escape pathway in soft tissue sarcomaIL-17A promotes the proliferation of human nasopharyngeal carcinoma cells through p300-mediated Akt1 acetylation.Pterostilbene, a natural phenolic compound, synergizes the antineoplastic effects of megestrol acetate in endometrial cancer.Physapubescin B inhibits tumorgenesis and circumvents taxol resistance of ovarian cancer cells through STAT3 signaling.Honokiol suppresses pancreatic tumor growth, metastasis and desmoplasia by interfering with tumor-stromal cross-talk.Kinome and Transcriptome Profiling Reveal Broad and Distinct Activities of Erlotinib, Sunitinib, and Sorafenib in the Mouse Heart and Suggest Cardiotoxicity From Combined Signal Transducer and Activator of Transcription and Epidermal Growth Factor RCorrelation between NM23 protein overexpression and prognostic value and clinicopathologic features of ovarian cancer: a meta-analysis.Long non-coding RNA H19 suppresses retinoblastoma progression via counteracting miR-17-92 cluster.(E)-2-methoxy-4-(3-(4-methoxyphenyl)prop-1-en-1-yl)phenol suppresses ovarian cancer cell growth via inhibition of ERK and STAT3.Ruxolitinib synergistically enhances the anti-tumor activity of paclitaxel in human ovarian cancer.Biochemical Properties of a Decoy Oligodeoxynucleotide Inhibitor of STAT3 Transcription Factor.A natural ent‑kaurane diterpenoid induces antiproliferation in ovarian cancer cells via ERK1/2 regulation and inhibition of cellular migration and invasion
P2860
Q33835932-70A967D6-0532-4D40-8578-D7AE1BE77765Q36689024-F1DCF6FA-83B9-4475-BFA7-167C475DC0B0Q36853866-D936F933-4847-4A0F-8404-D93D70FD2FC0Q37022535-76D0AFCC-9EA7-4A93-A7F0-33630CDDD15AQ37701501-1C22CACB-DE54-4116-BE2D-DED3ADBCE555Q37725643-F53E9103-8553-4773-9122-3E9EBF72182CQ38734014-22B00958-FD7C-49F4-8139-08775FE0ABAEQ38787562-21730DF0-629E-42C3-ACB7-8795EFD683A2Q39171305-D9D92633-FB67-4E0A-87D2-D184B11CB42BQ39326252-2D14448F-5783-4299-9E82-0FAE05F4C792Q40128358-905611B0-9F81-456A-B607-90A629F83D7DQ40996325-2CABB69E-4E74-4BB9-898C-397E1CC17DB7Q41899539-2DA83B50-7288-424D-A07C-CA3FDEA6A8F4Q42371820-9FAACEBA-5F93-4B22-BE2C-1F8EE741BA92Q42378411-0EB4CA01-0CD8-45AF-AE57-724032E46E22Q42728448-57B17930-D526-4C7B-A0D2-A4A5C329113BQ47107119-63AB7822-EC3A-4E78-8FC9-2878B0BFA81EQ47255619-23F4F35D-C26A-4172-8F73-7C2B95514570Q47587240-132F58FB-75AD-47D4-8C5F-6FB77E73E244Q48145523-C1A18E55-272D-4B3C-8D5A-8758FB8506BFQ55084775-6C01EC9A-EC90-4069-9CE2-B82CED9083F8Q55642764-6BC6DE35-2082-4FD1-AD0D-F268F94C1112Q58792243-6E8BB398-B08B-488F-86D5-90D5D81CD347
P2860
Synergistic anti-tumor effect of combined inhibition of EGFR and JAK/STAT3 pathways in human ovarian cancer.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Synergistic anti-tumor effect ...... hways in human ovarian cancer.
@ast
Synergistic anti-tumor effect ...... hways in human ovarian cancer.
@en
type
label
Synergistic anti-tumor effect ...... hways in human ovarian cancer.
@ast
Synergistic anti-tumor effect ...... hways in human ovarian cancer.
@en
prefLabel
Synergistic anti-tumor effect ...... hways in human ovarian cancer.
@ast
Synergistic anti-tumor effect ...... hways in human ovarian cancer.
@en
P2093
P2860
P1433
P1476
Synergistic anti-tumor effect ...... hways in human ovarian cancer.
@en
P2093
David Horne
Ernest S Han
John H Yim
Meng-Yin Hsieh
Ralf Buettner
Richard Jove
P2860
P2888
P356
10.1186/S12943-015-0366-5
P577
2015-05-01T00:00:00Z
P5875
P6179
1051768263